News
Eli Lilly is buying Verve Therapeutics, developer of gene-editing treatments for cardiovascular disease, for $1 billion plus ...
Coinbase (NASDAQ:COIN) is working to gain approval from the U.S. Securities and Exchange Commission to offer "tokenized equities" to its customers, the company’s chief legal officer Paul Grewal told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results